Vor Biopharma Inc. (VOR) Tops Q2 EPS by 1c
Tweet
Share
E-mail
Get Alerts VOR Hot Sheet
Join SI Premium – FREE
Vor Biopharma Inc. (NASDAQ: VOR) reported Q2 EPS of ($0.41), $0.01 better than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
- Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
